Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention.
Find Out More About Us
Find Out More About Our Pipeline
Find Out More About Our Target Markets
13 April 2023
Audited results for year ended 31 December 2022
04 April 2023
Landmark data published on NTCD-M3